AU2001277786A1 - Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase - Google Patents
Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinaseInfo
- Publication number
- AU2001277786A1 AU2001277786A1 AU2001277786A AU7778601A AU2001277786A1 AU 2001277786 A1 AU2001277786 A1 AU 2001277786A1 AU 2001277786 A AU2001277786 A AU 2001277786A AU 7778601 A AU7778601 A AU 7778601A AU 2001277786 A1 AU2001277786 A1 AU 2001277786A1
- Authority
- AU
- Australia
- Prior art keywords
- composition containing
- matrix metalloproteinase
- ginkgo biloba
- inhibit angiogenesis
- containing ginkgo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000008100 Ginkgo biloba Nutrition 0.000 title 1
- 244000194101 Ginkgo biloba Species 0.000 title 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 title 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 title 1
- 230000033115 angiogenesis Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2000-0045265A KR100417172B1 (en) | 2000-08-04 | 2000-08-04 | Angiogenesis inhibitor containing ginkgo biloba extract |
| KR0045265 | 2000-08-04 | ||
| KR0111850 | 2001-03-07 | ||
| KR10-2001-0011850A KR100477507B1 (en) | 2001-03-07 | 2001-03-07 | Pharmaceutical composition containing ginkgo biloba extract for the use of matrix metalloproteinase inhibitor |
| PCT/KR2001/001325 WO2002011745A1 (en) | 2000-08-04 | 2001-08-03 | Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001277786A1 true AU2001277786A1 (en) | 2002-02-18 |
Family
ID=26638280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001277786A Abandoned AU2001277786A1 (en) | 2000-08-04 | 2001-08-03 | Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001277786A1 (en) |
| WO (1) | WO2002011745A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2536604A1 (en) * | 2002-08-30 | 2004-03-11 | Biopharmacopae Design International Inc. | Plant extracts for treatment of angiogenesis and metastasis |
| JP5102434B2 (en) * | 2002-09-09 | 2012-12-19 | ネステク ソシエテ アノニム | Orally administrable composition for improving skin quality |
| FR2857266B1 (en) * | 2003-07-07 | 2007-09-21 | Jean Noel Thorel | COMPOSITION FOR DERMATOLOGICAL AND / OR COSMETIC USE, COMPRISING AS ACTIVE INGREDIENT AT LEAST ONE LIPOPHILIC ANTIOXIDANT |
| KR20050081597A (en) * | 2004-02-16 | 2005-08-19 | 한국 메디텍 제약 주식회사 | Drug for osteoporosis having inhibition effect on cancer comprising ginkgo biloba extracts as the active ingredient |
| JP5294536B2 (en) * | 2005-03-31 | 2013-09-18 | 小林製薬株式会社 | Gingival epithelial cell spreading inhibitor |
| CN104857040A (en) * | 2015-06-03 | 2015-08-26 | 广西梧州制药（集团）股份有限公司 | New purpose of embelia parviflora wall for preparing medicines for treating liver fibrosis |
| CN104940257B (en) * | 2015-06-03 | 2018-12-18 | 广西梧州制药（集团）股份有限公司 | Purposes of the smallflower embelia root and stem in terms of preparation treatment and/or prevention cell aberration drug |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2634380B1 (en) * | 1988-07-19 | 1990-10-12 | Beljanski Mirko | BIOLOGICAL REGULATOR, ACTIVE IN VARIOUS PATHOLOGIES |
| WO2001012208A1 (en) * | 1999-08-12 | 2001-02-22 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Use of ginkgo extract |
-
2001
- 2001-08-03 AU AU2001277786A patent/AU2001277786A1/en not_active Abandoned
- 2001-08-03 WO PCT/KR2001/001325 patent/WO2002011745A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002011745A1 (en) | 2002-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301452A3 (en) | Pharmaceutical composition containing photochemotherapeutic agent and mucoadhesive agent and its use | |
| GB2352177B (en) | Composition from ginkgo biloba leaves preparation and uses | |
| SI1329456T1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
| HUP0203965A3 (en) | Indazole compounds and pharmaceutical compositions containing them | |
| IL152451A0 (en) | 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same | |
| IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
| HUP0303621A3 (en) | Pharmaceutical compositions containing combinations comprising an antidiarrheal agent and epothilone or an epothilone | |
| HUP0400691A3 (en) | Pyrimidineamines as angiogenesis modulators and pharmaceutical compositions containing them | |
| HUP0302881A3 (en) | Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid | |
| IL155196A0 (en) | Benzamide derivatives and pharmaceutical compositions containing the same | |
| IL152718A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
| HUP0104768A3 (en) | 4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same | |
| HUP0300798A3 (en) | Substituted-triazolopyrimidines and their use as anticancer agents and pharmaceutical compositions containing them | |
| IL206621A0 (en) | Caspase inhibitors and pharmaceutical compositions containing the same | |
| AU7645701A (en) | Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides | |
| IL150383A0 (en) | Glyburide and pharmaceutical compositions containing the same | |
| HUP0302455A3 (en) | Combination pharmaceutical compositions containing amplodipine and benazepril and their use | |
| IL156577A0 (en) | Selective cathepsin s inhibitors and pharmaceutical compositions containing the same | |
| IL137363A0 (en) | Pharmaceutical compositions containing mupirocin | |
| IL152978A0 (en) | Macromolecular drug complexes and compositions containing the same | |
| HUP0200747A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
| AU2001277786A1 (en) | Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase | |
| ZA200006020B (en) | Voacamine as anti-malarial agent and anti-malarial agent containing voacamine. | |
| IL141654A0 (en) | Pyranose derivatives and pharmaceutical compositions containing the same |